Recombinant protein corresponding to SARS-CoV-2 Nucleoprotein.
Alternative Names:
sars-cov-2
Severe acute respiratory syndrome (SARS) is a lower respiratory tract illness that was first reported in patients from the Guandong Province of China in November 2002. The causative agent, which was previously unknown, was isolated in 2003 and named as S
Purity:
Purified by Protein A affinity chromatography.
Form:
Supplied as a liquid in PBS, 0.09% sodium azide.
* VAT and and shipping costs not included. Errors and price changes excepted